2023
DOI: 10.1016/j.ygeno.2022.110553
|View full text |Cite
|
Sign up to set email alerts
|

Hsa_circ_0049396 inhibited oral squamous cell carcinoma progression by regulating the miR-663b/ENDOU axis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 23 publications
0
0
0
Order By: Relevance
“…Human EndoU (hEndoU) was first identified as human placental protein 11 (PP11) due to its prevalence in the placenta [17,18]. It is also now recognized as a biomarker in various cancers, including squamous cell carcinomas, ovarian adenocarcinomas, non-trophoblastic tumors and breast cancers [19,20,21,22,23,24]. In human cells, EndoU has been proposed to be involved in RNA cleavage, ribonucleoprotein particle removal, and endoplasmic reticulum network organization [25,26].…”
Section: Introductionmentioning
confidence: 99%
“…Human EndoU (hEndoU) was first identified as human placental protein 11 (PP11) due to its prevalence in the placenta [17,18]. It is also now recognized as a biomarker in various cancers, including squamous cell carcinomas, ovarian adenocarcinomas, non-trophoblastic tumors and breast cancers [19,20,21,22,23,24]. In human cells, EndoU has been proposed to be involved in RNA cleavage, ribonucleoprotein particle removal, and endoplasmic reticulum network organization [25,26].…”
Section: Introductionmentioning
confidence: 99%